Abstract
Purpose
Zygotes with 2.1 pronuclei (2.1PN) present with two normal-sized pronuclei, and an additional smaller pronucleus, that is approximately smaller than two thirds the size of a normal pronucleus. It remains unclear whether the additional pronucleus causes embryonic chromosome abnormalities. In the majority of cases, in vitro fertilization (IVF) clinics discarded 2.1PN zygotes. Thus, the present study aimed to evaluate the developmental potential and value of 2.1PN zygotes.
Methods
2.1PN-derived embryos from 164 patients who underwent IVF or intracytoplasmic sperm injection (ICSI) treatment between January 2021 and December 2022 were included in the present study. All embryos were monitored using a time-lapse system, and blastocyst formation was used to assess 2.1PN-derived embryo developmental potential. The blastocyst formation was quantified using generalized estimating equations, and chromosome euploidy was analyzed using next-generation sequencing (NGS). In addition, the potential association between age and occurrence of 2.1PN zygotes was determined.
Results
The present study demonstrated that numerous 2.1PN zygotes developed into blastocysts. Early cleavage patterns and embryo quality on Day 3 were the independent predictors for the blastocyst formation of 2.1PN-derived embryos. The 2.1PN zygotes displayed a comparable developmental potential compared to 2PN zygotes in advanced age patients (≥ 38). Moreover, there was a tendency that 2.1PN-derived blastocysts showed a similar euploidy rate compared to 2PN-derived blastocysts.
Conclusion
Clinicians should consider using 2.1PN-derived euploid embryos for transfer after preimplantation genetic testing in the absence of available 2PN embryo cycles. 2.1PN-derived embryos could be a candidate, particularly beneficial for patients at advanced age.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Alpha Scientists in Reproductive MedicineEuropean Society for Human Reproduction and Embryology Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270–83.
Lim AS, Goh VH, Su CL, Yu SL. Microscopic assessment of pronuclear embryos is not definitive. Hum Genet. 2000;107(1):62–8.
Staessen C, Van Steirteghem AC. The chromosomal constitution of embryos developing from abnormally fertilized oocytes after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod. 1997;12(321–7):11.
Mutia K, Wiweko B, Iffanolida PA, Febri RR, Muna N, Riayati O, Jasirwan SO, Yuningsih T, Mansyur E, Hestiantoro A. The frequency of chromosomal euploidy among 3PN embryos. J Reprod Infertil. 2019;20(3):127–31.
Capalbo A, Treff N, Cimadomo D, Tao X, Ferrero S, Vaiarelli A, Colamaria S, Maggiulli R, Orlando G, Scarica C, Scott R, Ubaldi FM, Rienzi L. Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization cycles. Fertil Steril. 2017;108:1007–15.
Takahashi H, Hirata R, Otsuki J, Habara T, Hayashi N. Are tri-pronuclear embryos that show two normal-sized pronuclei and additional smaller pronuclei useful for embryo transfer? Repord Med Biol. 2022;21(1):e12462.
Ezoe K, Takahash T, Shimazaki K, Miki T, Tanimura Y, Amagai A, Sawado A, Akaike H, Mogi M, Kaneko S, Kato M, Kato K, Tarozzi N, Borin A, Coticchio G. Human 1PN and 3PN zygotes recapitulate all morphokinetic events of normal fertilization but reveal novel developmental errors. Hum Reprod. 2022;37(10):2307–19.
Caroselli S, Figliuzzi M, Cogo F, Zambon P, Favero F, Anastasi A, Capodanno F, Gallinelli A, Cimadomo D, Rienzi L, Ubaldi F, Miravet-Valenciano J, Blesa-Jarque D, Simon C, Capalbo A. Improved clinical validity of Preimplantation Genetic Testing for Aneuploidy (PGT-A) using a next-generation sequencing workflow for simultaneous detection of aneuploidy, ploidy and common pathogenic microdeletions. Hum Reprod. 2023-04-03;38(4):762–5.
World Health Organization. WHO laboratory manual for the Examination and processing of human semen (5th ed.) World Health Organization. 2010. https://apps.who.int/iris/handle/10665/343208.
Xiong S, Li W, Wang J, Liu J, Gao Y, Wu L, Zhu J, Hao X, Li J, Liu D, Han W, Huang G. Trophectoderm biopsy protocols may impact the rate of mosaic blastocysts in cycles with pre-implantation genetic testing for aneuploidy. J Assist Reprod Genet. 2021;38(5):1153–62.
Xiong S, et al. Effects of cumulus cells removal after 6 h co-incubation of gametes on the outcomes of human IVF. J Assist Reprod Gen. 2011;28(12):1205–11.
Gardner DK, Schoolcraft WB. In vitro culture of human blastocyst. In: Mortimer JR, editor. Toward reproductive certainty: infertility and genetics beyond 1999: Carnforth. Parthenon Press; 1999. p. 378–88.
Kim KH, Kim EY, Lee KA. GAS6 ameliorates advanced age-associated meiotic defects in mouse oocytes by modulating mitochondrial function. Aging (Albany NY). 2021;13(14):18018–32.
Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet. 2012;13:493–504.
Sainte-Rose R, Petit C, Dijols L, Frapsauce C, Guerif F. Extended embryo culture is effective for patients of an advanced maternal age. Sci Rep. 2021;11(1):13499. https://doi.org/10.1038/s41598-021-92902-9.
Jasirwan S, Iffanolida P, Andika SV, Friska D, Wiweko B. Relationship between morphology of tripronuclear embryo and chromosomal abnormalities potential in intracytoplasmic sperm injection cycles. J Nat Sci Biol Med. 2019;10:S92–8.
Yalçınkaya E, Özay A, Ergin EG, Öztel Z, Özörnek H. Live birth after transfer of a tripronuclear embryo: An intracytoplasmic sperm injection as a combination of microarray and time-lapse technology. Turk J Obstet Gyneco. 2016;13(2):95–8.
Bardos J, Kwal J, Caswell W, Jahandideh S, Stratton M, Tucker M, DeCherney A, Devine K, Hill M, O’Brien JE. Reproductive genetics laboratory may impact euploid blastocyst and live birth rates: a comparison of 4 national laboratories’ PGT-A results from vitrified donor oocytes. Fertil Steril. 2023;119(1):29–35.
Yl Ma, Liu LW, Liu YX, Shi GH, Ai XX, Hou WH, Mai QY, Xu YW. Which type of chromosomal mosaicism is compatible for embryo transfer: a systematical review and meta-analysis. Arch Gynecol Obstet. 2022;306(6):1901–11.
Cascales A, Lledó B, Ortiz JA, Morales R, Ten J, Llácer J, Bernabeu R. Effect of ovarian stimulation on embryo aneuploidy and mosaicism rate. Syst Biol Reprod Med. 2021;67(1):42–9.
Yang HY, Liu Y, Niu WB, Yang Z, Wang Y, Jin HX, Li G. Correlation study of male semen parameters and embryo aneuploidy in preimplantation genetic testing for aneuploidy. Front Endocrinol (Lausanne). 2022;13:1072176.
Escriba C, Alambiaga A, Benavent M, Miret C, Garcia A, Lozano M, Gonzalez D, Crespo J, Teruel J. Embryo quality needs to be considered as a main criterion when selecting mosaic embryos for transfer. Hum Reprod. 2021; 36(Suppll1): deab 130.531. https://doi.org/10.1093/humrep/deab130.531.
Dang TT, Phung TM, Le H, Nguyen TB, Nguyen TS, Nguyen TL, Nga VT, Chu DT, Hoang VL, Nguyen DB. Preimplantation genetic testing of aneuploidy by next generation sequencing: association of maternal age and chromosomal abnormalities of blastocyst. Basic Clin Med Res Vietnam. 2019;30:4427–31.
Daughtry BL, Rosenkrantz JL, Lazar NH, Fei SS, Redmayne N, Torkenczy KA, Adey A, Yan M, Gao L, Park B, Nevonen KA, Carbone L, Chavez SL. Single-cell sequencing of primate preimplantation embryos reveals chromosome elimination via cellular fragmentation and blastomere exclusion. Genome Res. 2019;29(3):367–82.
Hardy K. Cell death in the mammalian blastocyst. Mol Hum Reprod. 1997;3:919–25.
Acknowledgements
We thank the physicians, technicians, and related staff of the Reproductive Medicine Center, Women and Children’s Hospital of Chongqing Medical University for their help and support. We also appreciate the patients who participated in this study.
Funding
This work was supported by the Women and Children’s Hospital of Chongqing Medical University (grant number: 2021YJQN07) and the Natural Science Foundation of Chongqing Province of China (grant number: CSTB2022NSCQ-MSX0253 and CSTB2023NSCQ-MSX0258).
Author information
Authors and Affiliations
Contributions
JW conducted the experiments and wrote the initial manuscript of the paper. SX and YG contributed to the data analysis. FX and HYL performed IVF and ICSI insemination. XWH and JYZ examined fertilization and collected patient’s information. NHG and WH conceived and designed the study, provided writing assistance and technical guidance. All authors contributed to the research discussion and manuscript revision. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Ethical approval was approved by the Ethics Committee of Women and Children’s Hospital of Chongqing Medical University (ethics approval no. 2021-RGI-10). All patients provided written informed consent.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, J., Xiong, S., Hao, X. et al. Evaluating the developmental potential of 2.1PN-derived embryos and associated chromosomal analysis. J Assist Reprod Genet (2024). https://doi.org/10.1007/s10815-024-03113-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10815-024-03113-w